Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
造血器腫瘍の治療剤
Document Type and Number:
Japanese Patent JP3986439
Kind Code:
B2
Abstract:
An inducing agent or enhancing agent, for the expression of HM1.24 antigen in hematopoietic tumor cells, comprising interferon alpha , interferon gamma , or the IRF-2 protein as an active ingredient, as well as an anti-tumor agent for hematopoietic tumors which comprises a combination of said inducing agent or enhancing agent and an antibody against HM1.24.

Inventors:
Masaaki Kosaka
Shuji Ozaki
Yuji Wakahara
Application Number:
JP2002563952A
Publication Date:
October 03, 2007
Filing Date:
February 06, 2002
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Chugai Pharmaceutical Co., Ltd.
International Classes:
C12N15/09; A61K38/17; A61K38/21; A61K39/395; A61K48/00; A61P19/00; A61P35/00; A61P35/02; C07K14/555; C07K16/30; C12N5/07; C12N5/077; C12N5/0781; C12N5/0783; C12N5/0784; C12N5/09; C12N15/12; C12Q1/02; C12Q1/68; G01N33/15; G01N33/50; G01N33/574; C12P21/08
Foreign References:
WO1994006818A1
Other References:
Blood,米国,1994年,Vol.94, No.10, Suppl.1, Part 1,549a
Nucleic. Acids. Res.,米国,2000年11月 1日,Vol.28, No.21,4219-4224
J. Cell Biol.,米国,1998年,Vol.140, No.5,1265-1276
Attorney, Agent or Firm:
Takashi Ishida
Jun Tsuruta
Fukumoto product
Masaya Nishiyama
Higuchi Souji